Get the Stockscreener App
1.3124
1.74%
0.0224
Medicinova Inc stock is traded at $1.3124, with a volume of 4,499.
It is up +1.74% in the last 24 hours and up +5.84% over the past month.
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.
See More
Previous Close:
$1.29
Open:
$1.32
24h Volume:
4,499
Relative Volume:
0.17
Market Cap:
$64.37M
Revenue:
-
Net Income/Loss:
$-9.51M
P/E Ratio:
-6.9074
EPS:
-0.19
Net Cash Flow:
$-10.96M
1W Performance:
+0.18%
1M Performance:
+5.84%
6M Performance:
-28.28%
1Y Performance:
+7.57%
1-Day Range:
$1.31
$1.33
1-Week Range:
$1.29
$1.35
52-Week Range:
$1.13
$2.55
Medicinova Inc Stock (MNOV) Company Profile
Name
Medicinova Inc
Sector
Industry
Phone
858-373-1500
Address
4275 EXECUTIVE SQUARE, LA JOLLA, CA
Compare MNOV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MNOV
Medicinova Inc
|
1.3124 | 64.25M | 0 | -9.51M | -10.96M | -0.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Medicinova Inc Stock (MNOV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-10-21 | Initiated | Maxim Group | Buy |
| Mar-25-19 | Resumed | B. Riley FBR | Buy |
| Mar-28-18 | Initiated | B. Riley FBR, Inc. | Buy |
| Apr-18-17 | Initiated | Credit Suisse | Outperform |
| Jan-04-13 | Reiterated | Ladenburg Thalmann | Buy |
| May-24-12 | Downgrade | MLV & Co | Buy → Hold |
| Oct-18-11 | Reiterated | MLV Capital | Buy |
| Jun-22-11 | Initiated | Global Hunter Securities | Buy |
| May-12-10 | Initiated | Wedbush | Outperform |
| Nov-12-08 | Reiterated | Ladenburg Thalmann | Buy |
| May-15-08 | Initiated | Rodman & Renshaw | Mkt Outperform |
| Jul-09-07 | Initiated | Punk, Ziegel & Co | Buy |
View All
Medicinova Inc Stock (MNOV) Latest News
MediciNova Inc. Rebound Backed by Sentiment ShiftJuly 2025 Outlook & Weekly High Conviction Ideas - beatles.ru
Does MediciNova Inc. qualify in momentum factor screeningQuarterly Portfolio Report & Consistent Return Strategy Ideas - Newser
What the charts say about MediciNova Inc. todayEarnings Growth Report & Safe Capital Growth Tips - Newser
Is this a good reentry point in MediciNova Inc.2025 EndofYear Setup & Technical Confirmation Alerts - Newser
Applying sector rotation models to MediciNova Inc.July 2025 News Drivers & Low Drawdown Momentum Trade Ideas - Newser
What MACD and RSI say about MediciNova Inc.Chart Signals & AI Enhanced Market Trend Forecasts - Newser
When is the best time to exit MediciNova Inc.July 2025 Big Picture & Safe Entry Point Identification - Newser
Has MediciNova Inc. formed a bullish divergenceJuly 2025 Patterns & Free Fast Entry Momentum Trade Alerts - Newser
MediciNova Inc. stock outlook for YEAR2025 Analyst Calls & Consistent Profit Trading Strategies - Newser
MediciNova Inc. stock prediction for this weekNew Guidance & Safe Entry Trade Reports - Newser
Q&A: MediciNova Chief Business Officer David Crean on developing biopharma - Digital Journal
Is MediciNova Inc. stock reversal real or fakeShare Buyback & High Accuracy Swing Trade Signals - Newser
How to track smart money flows in MediciNova Inc.New Guidance & Real-Time Market Trend Scan - Newser
How hedge fund analytics apply to MediciNova Inc. stockPortfolio Gains Report & Daily Growth Stock Investment Tips - Newser
Is it time to cut losses on MediciNova Inc.Weekly Investment Summary & Fast Exit and Entry Trade Guides - Newser
Multi factor analysis applied to MediciNova Inc.Weekly Risk Summary & AI Optimized Trading Strategy Guides - Newser
Pattern recognition hints at MediciNova Inc. upsideTrade Analysis Report & Verified Stock Trade Ideas - Newser
MediciNova Inc. stock volume spike explainedJuly 2025 Catalysts & Growth Focused Entry Point Reports - Newser
Visual trend scoring systems applied to MediciNova Inc.July 2025 Decliners & Consistent Growth Equity Picks - Newser
How high can MediciNova Inc. stock go2025 Top Gainers & Free Technical Pattern Based Buy Signals - Newser
Real time social sentiment graph for MediciNova Inc.Market Performance Recap & Safe Entry Momentum Tips - Newser
Is MediciNova Inc. stock entering bullish territoryRecession Risk & AI Forecast Swing Trade Picks - Newser
Why MediciNova Inc. stock attracts strong analyst attentionWeekly Profit Analysis & High Return Trade Guides - thegnnews.com
Multi asset correlation models including MediciNova Inc.July 2025 Closing Moves & Stepwise Trade Execution Plans - Newser
Will MediciNova Inc. benefit from macro trends2025 Earnings Surprises & Stepwise Trade Signal Implementation - Newser
MediciNova Posts Q2 2025 Earnings Miss, Market Reaction Mixed with Post-Earnings Recovery Potential - AInvest
Order flow analysis tools used on MediciNova Inc.Weekly Trade Report & Low Risk Entry Point Guides - Newser
Can machine learning forecast MediciNova Inc. recoveryJuly 2025 Pullbacks & Risk Adjusted Buy/Sell Alerts - Newser
Can MediciNova Inc. disrupt its industryJuly 2025 Pullbacks & Fast Momentum Stock Entry Tips - mustnews.co.kr
Using Python tools to backtest MediciNova Inc. strategiesInflation Watch & Consistent Return Investment Signals - Newser
Medicinova Inc Stock (MNOV) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):